Arcadia Biosciences (RKDA) Institutional Ownership $4.44 +1.06 (+31.36%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$3.76 -0.68 (-15.23%) As of 05:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Arcadia Biosciences (NASDAQ:RKDA)CurrentInstitutional OwnershipPercentage17.73%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$72.80KNumber ofInstitutional Sellers(last 12 months)0 Get RKDA Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcadia Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RKDA Institutional Buying and Selling by Quarter Arcadia Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Geode Capital Management LLC12,297$73K0.0%N/A0.904% 11/15/2023Sabby Management LLC32,705$110K0.1%-72.3%2.946% 11/14/2022Armistice Capital LLC1,609,850$850K0.0%N/A6.533% 2/11/2022MYDA Advisors LLC100,000$104K0.0%+66.7%0.451% 11/12/2021MYDA Advisors LLC60,000$124K0.0%+33.1%0.271% 8/17/2021Boothbay Fund Management LLC50,294$149K0.0%-18.3%0.236% 8/16/2021Schonfeld Strategic Advisors LLC15,500$46K0.0%N/A0.073% 8/16/2021State Street Corp36,300$108K0.0%N/A0.170% 8/13/2021Geode Capital Management LLC164,641$488K0.0%+82.9%0.772% 8/13/2021Vanguard Group Inc.791,412$2.35M0.0%+107.8%3.709% 8/12/2021Dimensional Fund Advisors LP50,501$150K0.0%+310.3%0.237% (Data available from 1/1/2016 forward) RKDA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RKDA shares? During the previous two years, the following institutional investors and hedge funds held shares of Arcadia Biosciences shares: Sabby Management LLC ($110K), Geode Capital Management LLC ($73K).Learn more on Arcadia Biosciences' institutional investors. What percentage of Arcadia Biosciences' stock is owned by institutional investors? 17.73% of Arcadia Biosciences' stock is owned by institutional investors. Learn more on RKDA's institutional investor holdings. Which institutional investors have been buying Arcadia Biosciences' stock? The following institutional investors have purchased Arcadia Biosciences' stock in the last 24 months: Geode Capital Management LLC ($12.30K). How much institutional buying is happening at Arcadia Biosciences? Institutional investors have bought a total of 12,297 shares in the last 24 months. This purchase volume represents approximately $72.80K in transactions. Related Companies SEED Institutional Ownership CEAD Institutional Ownership ORIS Institutional Ownership IVP Institutional Ownership SISI Institutional Ownership SANW Institutional Ownership CTVA Institutional Ownership BV Institutional Ownership AVO Institutional Ownership AGRO Institutional Ownership This page (NASDAQ:RKDA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
